Filters

Term Search
You can select from the dropdown list OR enter your own terms to refine the search.

Last Updated: 10/31/2025

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 924 publications

Vascular endothelial cells and angiogenesis.

Vascular endothelial cells and angiogenesis.

Journal: Pharmacological research
Published: October 04, 2025

Cutaneous Coccidioidomycosis Mimicking Rosacea in Immunosuppressed Patient, Arizona, USA, 2024.

Cutaneous Coccidioidomycosis Mimicking Rosacea in Immunosuppressed Patient, Arizona, USA, 2024.

Journal: Emerging infectious diseases
Published: September 29, 2025

Design and synthesis of novel 3,5-diphenyl pyrazolines acting as potent EGFR inhibitors with off-target antileukemic effect.

Design and synthesis of novel 3,5-diphenyl pyrazolines acting as potent EGFR inhibitors with off-target antileukemic effect.

Journal: Future medicinal chemistry
Published: September 15, 2025

Patient-Reported Tolerability of Selpercatinib Compared to Cabozantinib/Vandetanib: A Secondary Analysis of the LIBRETTO-531 Randomized-Controlled Trial in RET-Mutant Medullary Thyroid Cancer.

Patient-Reported Tolerability of Selpercatinib Compared to Cabozantinib/Vandetanib: A Secondary Analysis of the LIBRETTO-531 Randomized-Controlled Trial in RET-Mutant Medullary Thyroid Cancer.

Journal: Thyroid : official journal of the American Thyroid Association
Published: August 19, 2025

DFT Structural and UV-Vis Spectral Insights into Photosensitivity of Vandetanib: A Dual EGFR/SARS-CoV-2 Mpro Inhibitor.

DFT Structural and UV-Vis Spectral Insights into Photosensitivity of Vandetanib: A Dual EGFR/SARS-CoV-2 Mpro Inhibitor.

Journal: Pharmaceuticals (Basel, Switzerland)
Published: July 22, 2025

Extracellular vesicle-associated transcriptomic and proteomic biomarkers show in vitro potential for vandetanib treatment monitoring in anaplastic thyroid cancer.

Extracellular vesicle-associated transcriptomic and proteomic biomarkers show in vitro potential for vandetanib treatment monitoring in anaplastic thyroid cancer.

Journal: Scientific reports
Published: July 11, 2025

A Case of Micro-medullary Thyroid Carcinoma Presenting as Cancer of Unknown Primary.

A Case of Micro-medullary Thyroid Carcinoma Presenting as Cancer of Unknown Primary.

Journal: Cureus
Published: June 30, 2025

Inhibitory Effects of Vandetanib on Catecholamine Synthesis in Rat Pheochromocytoma PC12 Cells.

Inhibitory Effects of Vandetanib on Catecholamine Synthesis in Rat Pheochromocytoma PC12 Cells.

Journal: International journal of molecular sciences
Published: June 14, 2025

Design, synthesis, anticancer evaluation, biological screening, and computational study of novel 6,7-dimethoxyquinazoline derivatives as VEGFR-2 inhibitors and apoptotic inducers.

Design, synthesis, anticancer evaluation, biological screening, and computational study of novel 6,7-dimethoxyquinazoline derivatives as VEGFR-2 inhibitors and apoptotic inducers.

Journal: European journal of medicinal chemistry
Published: June 14, 2025

Targeting metabolic and epigenetic reprogramming in metastatic fumarate hydratase-deficient renal cell carcinoma.

Targeting metabolic and epigenetic reprogramming in metastatic fumarate hydratase-deficient renal cell carcinoma.

Journal: Clinical & experimental metastasis
Published: June 05, 2025

Design and identification of novel drug candidates targeting RET: Accurate drug affinity estimation using funnel metadynamics.

Design and identification of novel drug candidates targeting RET: Accurate drug affinity estimation using funnel metadynamics.

Journal: International journal of biological macromolecules
Published: May 08, 2025

Overcoming resistance in RET-altered cancers through rational inhibitor design and combination therapies.

Overcoming resistance in RET-altered cancers through rational inhibitor design and combination therapies.

Journal: Bioorganic chemistry
Published: May 06, 2025
Showing 1-12 of 924

Last Updated: 10/31/2025